<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">URO</journal-id>
<journal-id journal-id-type="hwp">spuro</journal-id>
<journal-title>Journal of Clinical Urology</journal-title>
<issn pub-type="ppub">2051-4158</issn>
<issn pub-type="epub">2051-4166</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/2051415813480352</article-id>
<article-id pub-id-type="publisher-id">10.1177_2051415813480352</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The management of antenatal hydronephrosis detected on routine prenatal ultrasound</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Westera</surname><given-names>Jurjen</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Lambrianides</surname><given-names>Andreas L</given-names></name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Meyer</surname><given-names>Jon-Paul</given-names></name>
</contrib>
<aff id="aff1-2051415813480352">Redcliffe Hospital, Australia</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-2051415813480352">Jon-Paul Meyer, Redcliffe Hospital, Urology, Locked Mail Bag 1, Anzac Avenue, Kippa Ring, Redcliffe, Queensland 4021, Australia. Email: <email>jpmeyer@doctors.org.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>7</month>
<year>2013</year>
</pub-date>
<volume>6</volume>
<issue>4</issue>
<fpage>249</fpage>
<lpage>253</lpage>
<history>
<date date-type="received">
<day>11</day>
<month>12</month>
<year>2012</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>1</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© British Association of Urological Surgeons 2013</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="society">British Association of Urological Surgeons</copyright-holder>
</permissions>
<abstract>
<p>Antenatal hydronephrosis (ANH) is a common abnormality seen on routine prenatal ultrasound. Although this condition is invariably transient and benign, it can result in a deterioration in renal function and other significant co-morbidities. Once detected, careful ultrasound monitoring of the ANH is recommended during pregnancy. Postnatal antibiotic prophylaxis should be commenced after birth whilst investigating in a stepwise fashion in order to elucidate the underlying cause of the hydronephrosis. The aim is to preserve renal function, prevent urinary tract infection, and protect the upper tracts.</p>
</abstract>
<kwd-group>
<kwd>Hydronephrosis</kwd>
<kwd>ultrasound</kwd>
<kwd>PUJ obstruction</kwd>
<kwd>ureteric reflux</kwd>
<kwd>management</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-2051415813480352" sec-type="intro">
<title>Introduction</title>
<p>Antenatal hydronephrosis (ANH) is one of the most common abnormalities detected on pre-natal ultrasound. It is reported in 1%–5% of pregnancies.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref>,<xref ref-type="bibr" rid="bibr2-2051415813480352">2</xref></sup> ANH represents a wide range of diagnoses, from transient benign conditions to conditions that can significantly affect renal function and result in significant morbidity. In this paper the authors review the aetiology of ANH and make recommendations for the pre- and postnatal initial management of ANH.</p>
</sec>
<sec id="section2-2051415813480352">
<title>Definition</title>
<p>The most common measurement used for assessing ANH is the anteroposterior diameter (APD) of the renal pelvis. As the normal diameter will change as the foetus grows, there are differing definitions for the early and late trimesters. In the second trimester the degrees of ANH are as follows: mild 4–7 mm, moderate 7–10 mm and severe &gt; 10 mm. In the third trimester: mild 7–9 mm, moderate 9–15 mm and severe &gt; 15 mm. Generalised acceptance of a lower cut-off of 4–5 mm shows a higher sensitivity in detecting post-natal pathology but can yield high rates of false positives.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref></sup></p>
<p>The rate of post-natal pathology is directly related to the severity of ANH. Post-natal pathology will be identified in foetuses with mild ANH in 11%, 45% in moderate ANH, and 88% of foetuses with severe ANH will have demonstrable post-natal pathology.<sup><xref ref-type="bibr" rid="bibr3-2051415813480352">3</xref></sup> Exceptions to this are vesicoureteric reflux (VUR) and distal ureteric obstructions, which have the same incidence rate across all severities.<sup><xref ref-type="bibr" rid="bibr3-2051415813480352">3</xref></sup> ANH is most likely to result in post-natal pathology when associated with parenchymal thinning, ureteric, calyceal dilation, chromosomal abnormalities and multi-system malformations.</p>
<p>The Society of Fetal Urology (SFU) designed a five-point numerical grading system. The grading system describes a spectrum based on the post-natal appearance of the renal pelvis, calyces and renal parenchyma.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref></sup> A mild hydronephrosis relates to a grading score of 1–2; a moderate to severe hydronephrosis relates to a score of 3–4. The SFU use this grading score as part of their consensus management plan for foetuses with ANH (<xref ref-type="table" rid="table1-2051415813480352">Table 1</xref>).</p>
<table-wrap id="table1-2051415813480352" position="float">
<label>Table 1.</label>
<caption>
<p>Society of Fetal Urology (SFU) grading system.</p>
</caption>
<graphic alternate-form-of="table1-2051415813480352" xlink:href="10.1177_2051415813480352-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="char" char="."/>
</colgroup>
<thead>
<tr>
<th align="left">SFU grading</th>
<th align="left">Patterns of renal sinus splitting</th>
</tr>
</thead>
<tbody>
<tr>
<td>0</td>
<td>No splitting</td>
</tr>
<tr>
<td>1</td>
<td>Urine in pelvis barely splits</td>
</tr>
<tr>
<td rowspan="2" valign="top">2</td>
<td>Urine fills intra-renal pelvis</td>
</tr>
<tr>
<td>Urine fills extra-renal pelvis and major calyces dilated</td>
</tr>
<tr>
<td>3</td>
<td>SFU Grade 2 and minor calyces uniformly dilated and parenchyma preserved</td>
</tr>
<tr>
<td>4</td>
<td>SFU Grade 3 and parenchyma thinning</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="section3-2051415813480352">
<title>Causes of ANH</title>
<p>The causes of ANH vary from transient benign conditions to severe potentially fatal conditions. The definitions of the causes and incidence of pathology are discussed below. See <xref ref-type="table" rid="table2-2051415813480352">Table 2</xref>.</p>
<table-wrap id="table2-2051415813480352" position="float">
<label>Table 2.</label>
<caption>
<p>Causes of antenatal hydronephrosis.</p>
</caption>
<graphic alternate-form-of="table2-2051415813480352" xlink:href="10.1177_2051415813480352-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
</colgroup>
<tbody>
<tr>
<td>Transient benign hydronephrosis</td>
</tr>
<tr>
<td>PUJ obstruction</td>
</tr>
<tr>
<td>Megaureter</td>
</tr>
<tr>
<td>VUR</td>
</tr>
<tr>
<td>MCDK</td>
</tr>
<tr>
<td>Posterior urethral valves</td>
</tr>
<tr>
<td>Ureterocele</td>
</tr>
<tr>
<td>Ectopic ureter</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-2051415813480352">
<p>PUJ: pelvico-ureteric junction; VUR: vesicoureteric reflux; MCDK: multicystic dysplastic kidney disease.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec id="section4-2051415813480352">
<title>Transient hydronephrosis</title>
<p>This is the most common cause of ANH. Its incidence ranges from 41% to 88%.<sup><xref ref-type="bibr" rid="bibr4-2051415813480352">4</xref><xref ref-type="bibr" rid="bibr5-2051415813480352"/>–<xref ref-type="bibr" rid="bibr6-2051415813480352">6</xref></sup> Possible aetiologies include insufficient maturation of the pelvico-ureteric junction (PUJ), natural folds that resolve as the foetus matures, and increased foetal urinary output.<sup><xref ref-type="bibr" rid="bibr7-2051415813480352">7</xref></sup> Invariably, this condition resolves in the neonatal period.</p>
</sec>
<sec id="section5-2051415813480352">
<title>PUJ obstruction</title>
<p>The finding of pelvicalyceal dilatation without hydronephrosis, commonly unilateral, is highly suggestive of PUJ obstruction. It is normally caused by intrinsic stenosis/valves, an insertion anomaly of the ureter, peri-pelvic fibrosis or as a result of crossing vessels. It is associated with an increased incidence of other urological anomalies including vesicoureteric reflux (VUR). The diagnosis of a PUJ obstruction is made with diuresis renography. Current consensus supports conservative management for neonates with unilateral obstruction and normal renal function. Surgical intervention (with a rate of 19%–25%) is usually reserved for neonates with indications such as impaired dynamic renal function and a single functioning kidney.<sup><xref ref-type="bibr" rid="bibr8-2051415813480352">8</xref>,<xref ref-type="bibr" rid="bibr9-2051415813480352">9</xref></sup></p>
</sec>
<sec id="section6-2051415813480352">
<title>VUR</title>
<p>Hydronephrosis on ultrasound may indicate VUR, which accounts for 10%–20% of ANH.<sup><xref ref-type="bibr" rid="bibr10-2051415813480352">10</xref>,<xref ref-type="bibr" rid="bibr11-2051415813480352">11</xref></sup> The incidence increases with the degree of sonographic obstruction; however, the grade of VUR does not correlate with the degree of hydronephrosis.<sup><xref ref-type="bibr" rid="bibr10-2051415813480352">10</xref></sup> A micturating cysto-urethrogram (MCUG) is used to assess the degree of VUR, which is then graded according to the International Reflux Study Classification.<sup><xref ref-type="bibr" rid="bibr12-2051415813480352">12</xref></sup></p>
</sec>
<sec id="section7-2051415813480352">
<title>Megaureter</title>
<p>The incidence of megaureter is 5%–10%, with the majority of cases spontaneously resolving.<sup><xref ref-type="bibr" rid="bibr13-2051415813480352">13</xref>,<xref ref-type="bibr" rid="bibr14-2051415813480352">14</xref></sup> Megaureter can be classified as refluxing, obstructed or both refluxing and obstructed. An obstructed megaureter is usually due to an aperistaltic segment of distal ureter, for which surgery may be required.</p>
</sec>
<sec id="section8-2051415813480352">
<title>Multicystic dysplastic kidney (MCDK)</title>
<p>MCDK is the replacement of normal renal parenchyma with multiple, non-communicating cysts of various sizes. It is often confused with PUJ obstruction until post-natal ultrasound scans (USS) and 99mTc dimercaptosuccinic acid (DMSA) scans have been performed. The incidence of MCDK in children with ANH is 4%–6%.<sup><xref ref-type="bibr" rid="bibr4-2051415813480352">4</xref></sup> This condition can be unilateral or bilateral. If bilateral there is associated anhydramnios and the bladder is “absent”.</p>
</sec>
<sec id="section9-2051415813480352">
<title>Posterior urethral valves (PUVs)/urethral atresia</title>
<p>It is reported that the identification of i. prenatal hydronephrosis (often bilateral); ii. a dilated, thick-walled bladder that fails to empty; iii. dilated posterior urethra; and iv. decreased amniotic fluid suggests the presence of a lower urinary tract obstruction.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref></sup> This most commonly causes a severe obstruction and a worse prognosis compared with other causes of ANH (responsible for ~ 1% of cases of ANH). Foetuses with PUVs are at risk of pulmonary hypoplasia and renal impairment (up to a third of patients). All suspected cases require urgent catheterisation after birth (indwelling (IDC) or supra-pubic (SPC)), and a USS and MCUG within 48 hours. Clinically there are three types of PUVs originally described by Hugh Hampton Young, with type one being the most common. Management options include endoscopic valve ablation, vesicostomy or high urinary diversion.</p>
</sec>
<sec id="section10-2051415813480352">
<title>Ureterocele</title>
<p>This is a cystic dilatation of the distal end of the ureter as it drains into the bladder. Ten per cent are bilateral, and 80% are associated with the upper pole of a duplex system. Ureterocoeles can cause obstruction and hydronephrosis. Single-system ureteroceles can be managed by endoscopic incision and later re-implantation if required. Management of duplex system ureteroceles varies, with options including an upper pole heminephrectomy.<sup><xref ref-type="bibr" rid="bibr7-2051415813480352">7</xref></sup></p>
</sec>
<sec id="section11-2051415813480352">
<title>Ectopic ureter</title>
<p>This describes a ureteric orifice (UO) situated below the normal anatomical insertion of the ureter on the bladder trigone. Eighty per cent are associated with a duplication of the collecting system. A duplex kidney has both an upper and lower pole, each with its own renal pelvis and ureter. The duplication may be partial (where the ureters join to form a single ureter) or complete, where the ureters pass down individually to the bladder. In a complete duplication, the upper pole ureter always opens onto the bladder below and medial to the lower pole ureter (Weigert-Meyer rule); this predisposes to ectopic placement of the UO.</p>
<p>An ectopic ureter is often associated with a poorly functioning renal upper pole; as such heminephrectomy or total nephrectomy may be required. In partial duplication where some function is retained, ureteric reimplantation may be required.<sup><xref ref-type="bibr" rid="bibr7-2051415813480352">7</xref></sup></p>
</sec>
</sec>
<sec id="section12-2051415813480352">
<title>Management</title>
<sec id="section13-2051415813480352">
<title>Pre-natal management</title>
<p>Nguyen et al. recommend that a diagnosis of ANH should be followed with a repeat USS scan in the pre-natal period. Depending on gender, gestational age, presence of ureteric dilation, presence of bilaterality, amniotic fluid volume status and APD of the renal pelvis, some patients should be imaged regularly during pregnancy.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref></sup></p>
<p>Mild hydronephrosis should be followed during the pregnancy. This is left to the discretion of the treating obstetrician, as most of these will resolve completely.<sup><xref ref-type="bibr" rid="bibr15-2051415813480352">15</xref></sup> Post-natal investigation is warranted when a mild hydronephrosis is still present in the third trimester.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref></sup></p>
<p>Foetuses that have an increase in the degree of hydronephrosis from the second to the third trimester are at increased risk of post-natal anomalies.<sup><xref ref-type="bibr" rid="bibr16-2051415813480352">16</xref></sup> Therefore, post-natal evaluation is strongly recommended in this group.</p>
<p>Ultrasonographic suspicion of a PUV requires close monitoring throughout pregnancy; in such cases all foetuses should have a level 3 ultrasound to exclude other congenital defects. Ultrasound surveillance may be required as often as every four weeks, depending on the degree of oligohydraminos. The presence of increasing oligohydraminos may be an indication for vesicoamniotic shunting, foetal cystoscopic valve ablation or open surgery.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref></sup> One of the important indications for intervention is the significant reduction of amniotic fluid during foetal lung maturation (18 to 24 weeks’ gestation).<sup><xref ref-type="bibr" rid="bibr17-2051415813480352">17</xref></sup> Oligohydraminos occurring after 30 weeks’ gestation is less concerning as lung maturation is at a more advanced stage; however, morbidity from the primary urological complaint is still apparent.</p>
<p>A gross predictor of renal function can be obtained by performing a foetal bladder tap to allow an analysis of foetal urine and biochemistry. A minimum of two taps are performed to determine whether there has been an improvement in renal function after decompression. If the results are favourable, then intervention may be offered.</p>
<p>A crucial part in the management of ANH is the appropriate and detailed multidisciplinary counselling of the future parents. The potential pre- and post-natal outcomes must be discussed; these include renal failure, the need for post-natal investigations, interventions, renal transplantation and foetal death. In addition the importance of ongoing follow-up must be stressed. The details of these pre-natal interventions are beyond the scope of this paper; however, it should again be stressed to the future parents that these interventions are high risk. The overall survival of foetuses undergoing prenatal intervention ranges from 40% to 70%, owing to the severity of the underlying condition being treated.<sup><xref ref-type="bibr" rid="bibr18-2051415813480352">18</xref>,<xref ref-type="bibr" rid="bibr19-2051415813480352">19</xref></sup> There are as yet no randomised control trials reporting on the success of these interventions.<sup><xref ref-type="bibr" rid="bibr18-2051415813480352">18</xref></sup></p>
</sec>
<sec id="section14-2051415813480352">
<title>Recommendation</title>
<p>We feel that all cases of ANH should be monitored during pregnancy with USS. In the presence of worsening ANH, consideration should be given to the early involvement of specialist antenatal intervention.</p>
<sec id="section15-2051415813480352">
<title>Post-natal management</title>
<p>This involves a multidisciplinary approach. Initial management includes a physical examination, an ultrasound and prophylactic antibiotics. The presence of abdominal masses (PUJ obstruction, multicystic kidney), palpable bladder (PUV) or abdominal wall defects with cryptorchid testis (prune-belly syndrome) should raise suspicion. Neonates should be commenced upon prophylactic antibiotics. Woodward and Frank suggest trimethoprim 2 mg/kg once daily until the neonate has been fully investigated.<sup><xref ref-type="bibr" rid="bibr7-2051415813480352">7</xref></sup></p>
<p>Renal ultrasonography should be performed within the first week of life and repeated again at six weeks, as relative oliguria in the first week of life may lead to false-negative results. Blood should be taken in the first 48 hours if there is hydronephrosis of a solitary kidney or suspicion of a bladder outlet obstruction or ureterocele and bilateral hydronephrosis.<sup><xref ref-type="bibr" rid="bibr7-2051415813480352">7</xref></sup></p>
<p>Persistent post-natal hydronephrosis should be further evaluated with an MCUG. During this investigation, a urethral catheter is used to instil contrast medium in the bladder, and bladder filling and voiding is examined with fluoroscopy. Adverse outcomes are rare in infants, and it is generally well tolerated. Prophylactic antibiotics are recommended.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref>,<xref ref-type="bibr" rid="bibr7-2051415813480352">7</xref></sup></p>
<p>The presence of VUR on the MCUG should prompt further investigation with a DMSA scan to look for renal scars (these appear as defects in the cortical outline in the polar regions of the kidneys, and these represent areas where the radioisotope is not taken up).</p>
<p>The absence of VUR and persistent hydronephrosis requires evaluation with diuresis renography, namely a mercapto acetyl triglycine (MAG-3) renogram. <sup>99</sup>Tc-MAG3 binds to plasma proteins and is excreted principally by tubular secretion (glomerular filtration is minimal); this determines the presence of renal obstruction as well as providing an estimation of split renal function.</p>
<p>There is not a worldwide consensus on the exact timing of renography in the post-natal period. The European Society of Paediatric Radiology recommends two USS three months apart before obtaining renal scintigraphy,<sup><xref ref-type="bibr" rid="bibr20-2051415813480352">20</xref></sup> whereas in the United States a single USS is deemed sufficient.<sup><xref ref-type="bibr" rid="bibr1-2051415813480352">1</xref></sup></p>
</sec>
</sec>
<sec id="section16-2051415813480352">
<title>Recommendation</title>
<p>We suggest that all neonates with persistent ANH be commenced upon prophylactic antibiotics at birth. Post-natal ultrasound findings will dictate further investigations. If the ANH has resolved on both the initial post-natal scan and subsequent USS at six weeks, the antibiotics should be stopped. If the ANH persists, an MCUG should be requested and depending on results followed with either a MAG-3 or DMSA. See <xref ref-type="table" rid="table3-2051415813480352">Table 3</xref>.</p>
<table-wrap id="table3-2051415813480352" position="float">
<label>Table 3.</label>
<caption>
<p>Management of antenatal hydronephrosis.</p>
</caption>
<graphic alternate-form-of="table3-2051415813480352" xlink:href="10.1177_2051415813480352-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Management aims</th>
</tr>
</thead>
<tbody>
<tr>
<td>• Preserve renal function</td>
</tr>
<tr>
<td>• Prevent urinary tract infection</td>
</tr>
<tr>
<td>• Protect the upper tracts</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="section17-2051415813480352" sec-type="conclusions">
<title>Conclusion</title>
<p>ANH is a common pre-natal anomaly detected on a “routine” ultrasound during pregnancy. Although it is most commonly a transient benign condition, it can also result from conditions which can cause significant morbidity. We suggest therefore that all ANH be monitored during pregnancy, and that there should be early involvement of multidisciplinary specialist care where appropriate. We feel that post-natal investigation should be initiated when hydronephrosis has been demonstrated to persist into the third trimester, and that the initial management should aim to preserve renal function, prevent infection, and protect the upper tracts.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Conflict of interest</label>
<p>The authors declare that there are no conflicts of interest.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-2051415813480352">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nguyen</surname><given-names>HT</given-names></name>
<name><surname>Herdon</surname><given-names>A</given-names></name>
<name><surname>Cooper</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis</article-title>. <source>J Paediatr Urol</source> <year>2010</year>; <volume>6</volume>: <fpage>212</fpage>–<lpage>231</lpage>.</citation>
</ref>
<ref id="bibr2-2051415813480352">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Blyth</surname><given-names>B</given-names></name>
<name><surname>Snyder</surname><given-names>HM</given-names></name>
<name><surname>Duckett</surname><given-names>JW</given-names></name>
</person-group>. <article-title>Antenatal diagnosis and subsequent management of hydronephrosis</article-title>. <source>J Urol</source> <year>1993</year>; <volume>149</volume>: <fpage>693</fpage>–<lpage>698</lpage>.</citation>
</ref>
<ref id="bibr3-2051415813480352">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>RS</given-names></name>
<name><surname>Cedron</surname><given-names>M</given-names></name>
<name><surname>Kinnamon</surname><given-names>DD</given-names></name>
<etal/></person-group>. <article-title>Antenatal hydronephrosis as a predictor of postnatal outcome: A meta-analysis</article-title>. <source>Paediatrics</source> <year>2006</year>; <volume>118</volume>: <fpage>586</fpage>–<lpage>593</lpage>.</citation>
</ref>
<ref id="bibr4-2051415813480352">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Mallik</surname><given-names>M</given-names></name>
<name><surname>Watson</surname><given-names>AR</given-names></name>
</person-group>. <article-title>Antenatally detected urinary tract abnormalities: More detection but less action</article-title>. <source>Pediatr Nephrol</source> <year>2008</year>; <volume>23</volume>: <fpage>897</fpage>–<lpage>904</lpage>.</citation>
</ref>
<ref id="bibr5-2051415813480352">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harding</surname><given-names>LJ</given-names></name>
<name><surname>Malone</surname><given-names>PS</given-names></name>
<name><surname>Wellesley</surname><given-names>DG</given-names></name>
</person-group>. <article-title>Antenatal minimal hydronephrosis: Is its follow-up an unnecessary cause of concern?</article-title> <source>Pregnat Diagn</source> <year>2000</year>; <volume>20</volume>: <fpage>206</fpage>–<lpage>209</lpage>.</citation>
</ref>
<ref id="bibr6-2051415813480352">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Saira</surname><given-names>S</given-names></name>
<name><surname>Al-Habib</surname><given-names>A</given-names></name>
<name><surname>Sasson</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Natural history of fetal hydronephrosis diagnosed on mid-trimester ultrasound</article-title>. <source>Ultrasound Obstet Gynecol</source> <year>2001</year>; <volume>17</volume>: <fpage>191</fpage>.</citation>
</ref>
<ref id="bibr7-2051415813480352">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Woodward</surname><given-names>M</given-names></name>
<name><surname>Frank</surname><given-names>D</given-names></name>
</person-group>. <article-title>Postnatal management of antenatal hydronephrosis</article-title>. <source>BJUI</source> <year>2002</year>; <volume>89</volume>: <fpage>149</fpage>–<lpage>156</lpage>.</citation>
</ref>
<ref id="bibr8-2051415813480352">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Palmer</surname><given-names>LS</given-names></name>
<name><surname>Maizels</surname><given-names>M</given-names></name>
<name><surname>Cartwright</surname><given-names>PC</given-names></name>
<etal/></person-group>. <article-title>Surgery versus observation for managing obstructive grade 3–4 unilateral hydronephrosis: A report from the Society for Fetal Urology</article-title>. <source>J Urol</source> <year>1998</year>; <volume>159</volume>: <fpage>222</fpage>–<lpage>228</lpage>.</citation>
</ref>
<ref id="bibr9-2051415813480352">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dhillon</surname><given-names>HK</given-names></name>
</person-group>. <article-title>Prenatally diagnosed hydronephrosis: The Great Ormond Street experience</article-title>. <source>Br J Urol</source> <year>1998</year>; <volume>81</volume>: <fpage>39</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr10-2051415813480352">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Brophy</surname><given-names>MM</given-names></name>
<name><surname>Austin</surname><given-names>PF</given-names></name>
<name><surname>Yan</surname><given-names>Y</given-names></name>
<etal/>
</person-group>. <article-title>Vesicoureteral reflux and clinical outcomes in infants with prenatally detected hydronephrosis</article-title>. <source>J Urol</source> <year>2002</year>; <volume>168</volume>: <fpage>1716</fpage>–<lpage>1719</lpage>.</citation>
</ref>
<ref id="bibr11-2051415813480352">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Phan</surname><given-names>VR</given-names></name>
<name><surname>Traubici</surname><given-names>J</given-names></name>
<name><surname>Hershenfield</surname><given-names>B</given-names></name>
<etal/></person-group>. <article-title>Vesicoureteral reflux in infants with isolated antenatal hydronephrosis</article-title>. <source>Pediatr Nephro</source> <year>2003</year>; <volume>18</volume>: <fpage>1224</fpage>–<lpage>1228</lpage>.</citation>
</ref>
<ref id="bibr12-2051415813480352">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lebowitz</surname><given-names>RL</given-names></name>
<name><surname>Olbing</surname><given-names>H</given-names></name>
<name><surname>Parkkulainen</surname><given-names>KV</given-names></name>
<etal/></person-group>. <article-title>International system of radiographic grading of vesicoureteric reflux. The International Reflux Study in Children</article-title>. <source>Pediatr Radiol</source> <year>1985</year>; <volume>15</volume>: <fpage>105</fpage>–<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr13-2051415813480352">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McLellan</surname><given-names>DL</given-names></name>
<name><surname>Retik</surname><given-names>AB</given-names></name>
<name><surname>Bauer</surname><given-names>SB</given-names></name>
<etal/>
</person-group>. <article-title>Rate and predictors of spontaneous resolution of prenatally diagnosed primary non-refluxing megaureter</article-title>. <source>J Urol</source> <year>2002</year>; <volume>168</volume>: <fpage>2177</fpage>–<lpage>2180</lpage>.</citation>
</ref>
<ref id="bibr14-2051415813480352">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shukla</surname><given-names>AR</given-names></name>
<name><surname>Cooper</surname><given-names>JR</given-names></name>
<name><surname>Patel</surname><given-names>RP</given-names></name>
<etal/>
</person-group>. <article-title>Prenatally detected primary megaureter: A role for extended followup</article-title>. <source>J Urol</source> <year>2005</year>; <volume>173</volume>: <fpage>1353</fpage>–<lpage>1356</lpage>.</citation>
</ref>
<ref id="bibr15-2051415813480352">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feldman</surname><given-names>DM</given-names></name>
<name><surname>DeCambre</surname><given-names>M</given-names></name>
<name><surname>Kong</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Evaluation and follow-up foetal hydronephrosis</article-title>. <source>J Ultrasound Med</source> <year>2001</year>; <volume>20</volume>: <fpage>1065</fpage>–<lpage>1069</lpage>.</citation>
</ref>
<ref id="bibr16-2051415813480352">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Aviram</surname><given-names>R</given-names></name>
<name><surname>Pomeranz</surname><given-names>A</given-names></name>
<name><surname>Sharony</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>The increase of renal pelvis dilatation in the fetus and its significance</article-title>. <source>Ultrasound Obstet Gynaecol</source> <year>2003</year>; <volume>102</volume>: <fpage>367</fpage>.</citation>
</ref>
<ref id="bibr17-2051415813480352">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peters</surname><given-names>CA</given-names></name>
</person-group>. <article-title>Lower urinary tract obstruction: Clinical and experimental aspects</article-title>. <source>Br J Urol</source> <year>1998</year>; <volume>81</volume>: <fpage>22</fpage>–<lpage>32</lpage>.</citation>
</ref>
<ref id="bibr18-2051415813480352">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kilby</surname><given-names>MD</given-names></name>
<name><surname>Daniels</surname><given-names>JP</given-names></name>
<name><surname>Khan</surname><given-names>K</given-names></name>
</person-group>. <article-title>Congenital lower urinary tract obstruction: To shunt or not to shunt?</article-title> <source>BJUI</source> <year>2006</year>; <volume>97</volume>: <fpage>6</fpage>–<lpage>8</lpage>.</citation>
</ref>
<ref id="bibr19-2051415813480352">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kousidis</surname><given-names>G</given-names></name>
<name><surname>Thomas</surname><given-names>DF</given-names></name>
<name><surname>Morgan</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>The long-term outcome of prenatally detected posterior urethral valves: A 10 to 23-year follow-up study</article-title>. <source>BJUI</source> <year>2008</year>; <volume>102</volume>: <fpage>1020</fpage>–<lpage>1024</lpage>.</citation>
</ref>
<ref id="bibr20-2051415813480352">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Riccabona</surname><given-names>M</given-names></name>
<name><surname>Avini</surname><given-names>FE</given-names></name>
<name><surname>Blickman</surname><given-names>JG</given-names></name>
<etal/>
</person-group>. <article-title>Imaging recommendations in paediatric uroradiology: Minutes of the ESPR workgroup session on urinary tract infection, fetal hydronephrosis, urinary tract ultrasonography and voiding cystourethrography, Barcelona, Spain, June 2007</article-title>. <source>Paediatric Radiolo</source> <year>2008</year>; <volume>38</volume>: <fpage>138</fpage>.</citation>
</ref>
</ref-list>
</back>
</article>